New Delhi: In one of the big news developments in the world of health, India on Tuesday developed its first indigenous vaccine ever. The rotavirus vaccine tackles diarrhoea that kills more than 1.6 lakh children every year.
The government has announced the results of Phase III clinical trials of the Rotavac vaccine, with 56 per cent efficacy rate. The vaccine could prevent a third of all diarrhoea deaths in Indian children, and should be ready in 8-9 months.
The new vaccine has been developed by the Department of Biotechnology in partnership with international groups like the Stanford University School of Medicine and NGO, PATH. Experts also claim that this new vaccine will be the cheapest globally.